SCHEDULE 13G/A: FMR LLC and Abigail P. Johnson Disclose 4.7% Passive Stake in Alto Neuroscience Inc.
Beneficial Ownership Report
FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, reporting a passive beneficial ownership of 4.7% of Alto Neuroscience Inc.'s common stock as of December 31, 2024.
Summary
- FMR LLC and Abigail P. Johnson, through a joint filing agreement, reported beneficial ownership of 1,265,546 shares of Alto Neuroscience Inc. common stock.
- This aggregate amount represents 4.7% of the total outstanding common stock of Alto Neuroscience Inc.
- FMR LLC holds sole voting power over 1,264,328 shares and sole dispositive power over 1,265,546 shares.
- Abigail P. Johnson holds sole dispositive power over 1,265,546 shares, with no sole or shared voting power.
- The filing is an Amendment No. 1 to a Schedule 13G, indicating a routine update to a previously reported passive investment.
- The ownership is reported as of December 31, 2024, and the filing date is February 11, 2025.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing disclosing passive beneficial ownership, containing factual information without expressing positive or negative sentiment regarding the issuer's performance or outlook.
Industry Context
This Schedule 13G filing is a standard regulatory disclosure by a major institutional investor, FMR LLC (Fidelity), detailing its passive ownership stake in Alto Neuroscience Inc. Such filings provide transparency on significant shareholdings and are common for large asset managers who hold positions for investment purposes rather than control.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional investor's passive stake in the company.
- Investment Professionals: Offers insight into institutional holdings and potential investor interest in Alto Neuroscience Inc.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of event which requires filing of this statement (reporting period end date for ownership calculation). |
| 02/11/2025 | Date of filing and signature by authorized representative. |
Keywords
Alto Neuroscience Inc, FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Passive Investment, SEC Filing, Biotechnology, Neuroscience
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.